1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 05 JANUARY 2015

Key Pharma News 05 JANUARY 2015

  • January 2015
  • -
  • Espicom Business Intelligence
  • -
  • 38 pages

Industry Trend Analysis - AbbVie HCV Approval Places Pressure On Gilead To Change Attitude To Drug Pricing
Industry Trend Analysis - Diagnostics Gaining Wider Utility In The Pharmaceutical Market
Industry Brief - Otsuka To Commercialise ARIAD's Iclusig In Asian Countries
Industry Brief - Angelini To Commercialise ARIAD's Iclusig In Central/Eastern Europe
Industry Brief - MacroGenics/Janssen Sign MGD011 Licensing Deal For Multiple B-Cell Malignancies
Industry Brief - OncoGenex To Regain Rights To Custirsen From Teva
Industry Trend Analysis - Another Partnership Advances Into BTK Inhibitor Field For Haematological Cancers
Industry Brief - Baxter To Sell Vero Cell Vaccines Platform To Nanotherapeutics
Industry Brief - Merck Commences Tender Offer To Acquire Cubist
Industry Brief - Abbott Completes Veropharm Acquisition
Industry Brief - Merck Gains BET Inhibitor Through OncoEthix Acquisition
Industry Trend Analysis - Keytruda And Opdivo Go Head To Head In Increasingly Competitive Market
Industry Trend Analysis - Cobimetinib/Zelboraf Combination Set To Take Melanoma Market Share
Industry Brief - Jazz' Erwinaze IV Gains FDA Approval For ALL
Industry Brief - NICE Issues Negative Decision For Abraxane In MPC
Industry Trend Analysis - Namenda Hard Switch Case Will Have Wider Implications
Industry Brief - FDA Accepts For Review sNDA For Deltoid Administration Of Abilify Maintena
Industry Brief - FDA Approves Actavis/Adamas' Namzaric
Industry Trend Analysis - Xadago For Parkinson's To See EC Approval And FDA Decision In H115
Industry Brief - Express Scripts Covers AbbVie's Viekira Pak For HCV But Excludes Harvoni/Sovaldi
Industry Brief - FDA Approves Gazyva sBLA For Treatment Naïve CLL Patients
Industry Brief - Novo Nordisk Receives FDA Approval Of Saxenda For Obesity
Industry Brief - Sanofi Receives FDA Approval For Fluzone Intradermal Quadrivalent Vaccine
Industry Brief - Taiho Completes TAS-102 NDA Submission To FDA For MCRC
Industry Brief - Orexigen's Mysimba Receives Positive CHMP Opinion
Industry Trend Analysis - Lynparza's Approval Will Benefit Myriad's Diagnostic Offerings
Industry Brief - FDA Approves BioCryst's Rapivab For Acute Uncomplicated Flu
Industry Brief - Actelion Submits Selexipag NDA To FDA For PAH
Industry Brief - Poteligio Approved In Japan For Chemotherapy-Native CCR4-positive ATL
Industry Brief - Takeda Submits Glatiramer Acetate NDA In Japan For Relapse Prevention Of MS
Industry Trend Analysis - Gardasil 9 FDA Approval To Advance HPV Vaccine Landscape
Industry Brief - Zelboraf/cobas 4800 BRAF V600 Mutation Test Gain Japanese Approval
Industry Brief - Janssen/USAID Sign MoU To Expand Access To MDR-TB Compound
Industry Trend Analysis - Somatuline Depot To Procure Strong Sales Following FDA Approval For GEP-NET Indication
Industry Brief - Apotex' Pegfilgrastim Biosimilar Accepted By FDA
Industry Brief - CHMP Adopts Positive Opinion On Velcade For MCL
Industry Brief - Chugai Seeks Japanese Approval For Additional Indication Of Xeloda
Industry Brief - FDA Approves Cubist's Zerbaxa For cUTIs and cIAIs
Industry Brief - Spectrum Seeks FDA Approval For Captisol-Enabled Melphalan
Industry Brief - Novartis' Cosentyx Approved In Japan For Psoriasis Vulgaris/PsA
Industry Trend Analysis - 2015 Will Bring Brexpiprazole's Approval And Patent Cliff For Otsuka
Industry Brief - First Patient Enrolled In Pradaxa Phase III Study For Reduction Of Recurrent Stroke
Industry Brief - Lundbeck Discontinues Further Development Of Desmoteplase
Industry Brief - Pfizer Reports Top-Line Results From Phase III Study Of Pregabalin CR In PHN
Industry Brief - GSK's Shingles Vaccine Candidate Meets Primary Endpoint In Phase III Study
Industry Brief - Roche To Discontinue Gantenerumab Phase III Study In Prodromal AD
Industry Brief - SDP Reports Preliminary Findings From Lurasidone Phase III Study In Schizophrenia
Industry Brief - European Consortium Formed To Advance Development Of Ebola Vaccine Candidate
Industry Trend Analysis - Cosentyx' Future Is Bright As It Clears A Path In Plaque Psoriasis
Industry Brief - Auspex Reports Positive Top-Line Results From SD-809 Phase III Trial For HD-Associated Chorea
Industry Trend Analysis - Return Of Failed Drugs Will Bolster Pfizer's Haematology Pipeline
Industry Trend Analysis - Disappointing First-Line Kadcyla Results Impacts HER2 Franchise

Table Of Contents

Key Pharma News 05 JANUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.